Pulmokine Receives $1,000,000 New Financing Round

  • Feed Type
  • Date
    3/5/2015
  • Company Name
    Pulmokine
  • Mailing Address
    7 University Place Rensselaer, NY 12144 USA
  • Company Description
    Pulmokine is a privately held biopharmaceutical company. Our focus is on pulmonary disease and kinase inhibitor technology, hence our name Pulmokine.
  • Website
    http://www.pulmokine.net
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor